~ Announced FDA clearance of Investigational New Drug application for AMT-260 in refractory mesial temporal lobe epilepsy ~ ~ On track to provide clinical update from U.S. and European Phase I/II.
uniQure Inc : uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
RESEARCH TRIANGLE PARK, N.C., Aug. 15, 2023 Science 37 Holdings, Inc. , the clinical research industry-leading Metasite™ is proud to announce its nomination for the prestigious 2023 Prix. -Today at 08:00 am- MarketScreener